TenSixty Bio
TenSixty Bio is an oncology-focused biotechnology company based in Cambridge, Massachusetts, working to revolutionize the treatment of cancer. The company combines biology, machine learning, and high-throughput technologies to build an atlas of antibody targets on the surface of cancer cells, discover novel cancer targets, and develop improved therapeutics from bench to bedside. TenSixty Bio is a privately held research-stage company backed by General Catalyst and Wing Venture Capital, and it does not currently publish a public API, developer portal, or SDKs. This profile was surfaced through the API Evangelist venture-capital portfolio pipeline and enriched with verified public company identity.
TenSixty Bio is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Oncology, Cancer, and Machine Learning.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Company 1
The organization behind the API